Milan Puskar Net Worth Overview
Milan Puskar is an American businessman best known as the co-founder of Mylan Inc., a global pharmaceutical company. His Milan Puskar net worth is primarily derived from his ownership stake in Mylan and subsequent investments. Public filings and financial reports estimate his net worth in the hundreds of millions, with fluctuations tied to Mylan stock performance and private asset valuations. The latest available public data reflects his position among prominent American pharmaceutical entrepreneurs.
The core of Milan Puskar wealth comes from his role in building Mylan from a generic drug distributor into a major global pharmaceutical manufacturer. His net worth is closely linked to the company's market capitalization, earnings growth, and strategic acquisitions over decades. While he stepped back from daily operations, his retained equity and investment portfolio continue to define his financial standing. This Milan Puskar net worth profile is based on SEC filings, corporate disclosures, and reliable financial news sources.
Career and Companies Behind the Wealth
Milan Puskar co-founded Milan Puskar and Don Panoz in 1961 to import and distribute generic pharmaceuticals, which later became Mylan Inc. Under his leadership, the company expanded through acquisitions and developed a portfolio of generic and branded drugs. Mylan's growth trajectory, including its public listing and subsequent corporate moves, directly shaped the wealth accumulation of its founders. His career is defined by building one of the largest generic drug companies in the world.
Mylan Inc. became a publicly traded company on major exchanges, and its financial performance is documented in annual reports and SEC filings. Milan Puskar served as chairman and CEO, guiding the company through multiple industry cycles and regulatory changes. The company's revenue, market share in generic drugs, and product portfolio are key factors in understanding the scale of his business influence. Detailed company history and financial data are available through official corporate and regulatory sources.
Investments and Financial Profile
Beyond Mylan, Milan Puskar has held investments in private equity, real estate, and other business ventures. His financial profile includes a diversified asset base that supports long-term wealth preservation. Public records and financial disclosures provide insight into his holdings, though much of his portfolio remains private. These investments complement the value generated by his pharmaceutical industry career.
Forbes and other financial outlets regularly track the net worth of pharmaceutical billionaires and business leaders, including former Mylan executives. Milan Puskar's financial standing is often referenced in rankings of influential business figures in the healthcare sector. His wealth is evaluated alongside other industry leaders based on public equity holdings, private assets, and philanthropic activities. Comprehensive financial profiles and business data can be explored through dedicated business and financial information platforms.